Edgewise Therapeutics EWTX
NASDAQ EWTX
$47.57 +1.04 (+2.24%)
As of: Nov 11, 2026 · 3:59 PM EST

Edgewise Therapeutics (EWTX) Change in Accrued Expenses (2020 - 2026)

Updated

Edgewise Therapeutics' Change in Accured Expenses was $2.9 million in Q2 2026, up 74.5% from $1.66 million a year earlier.

Analysis

Edgewise Therapeutics (EWTX) Change in Accrued Expenses (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, Edgewise Therapeutics' Change in Accured Expenses was $2.94 million through Jun 30, 2026, up 111.2% year-over-year; for FY2025, it came in at $2.37 million, down 45.6% from FY2024.

  • Change in Accured Expenses shows a five-year compound annual growth rate of 18.8% (FY2020 to FY2025).
  • In earlier years, Change in Accured Expenses was $4.36 million in FY2024 (+162.2%), $1.66 million in FY2023 (+24.5%), $1.34 million in FY2022 (-51.3%) and $2.75 million in FY2021 (+173.5%).
  • Quarterly Change in Accured Expenses has moved between -$6.75 million (Q1 2026) and $4.43 million (Q4 2025) over five years.
  • The best year-over-year quarter for Change in Accured Expenses over five years was Q3 2021 (growth of 718.3%); the worst was Q3 2022 (a decline of 69.1%).
  • Per Business Quant data, EWTX's Change in Accured Expenses in the three quarters before Q2 2026 was -$6.75 million (Q1 2026), $4.43 million (Q4 2025) and $2.36 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accrued Exp. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.41 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 983.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -87.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 756.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Edgewise Therapeutics 5.09 Bn 2.32 Bn - 8.28 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 8.28 Mn
Jun 30, 2026 2.90 Mn
Mar 31, 2026 -6.75 Mn
Dec 31, 2025 4.43 Mn
Sep 30, 2025 2.36 Mn
Jun 30, 2025 1.66 Mn
Mar 31, 2025 -6.08 Mn
Dec 31, 2024 3.87 Mn
Sep 30, 2024 1.94 Mn
Jun 30, 2024 1.32 Mn
Mar 31, 2024 -2.77 Mn
Dec 31, 2023 1.29 Mn
Sep 30, 2023 -571,000.00
Jun 30, 2023 2.91 Mn
Mar 31, 2023 -1.96 Mn
Dec 31, 2022 1.53 Mn
Sep 30, 2022 582,000.00
Jun 30, 2022 678,000.00
Mar 31, 2022 -1.45 Mn
Dec 31, 2021 -551,000.00
API Access

Edgewise Therapeutics Change in Accrued Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=EWTX&period=max&api_key=YOUR_API_KEY